Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
, 53 (RR-6), 1-40

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Affiliations
  • PMID: 15163927
Guideline

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Scott A Harper et al. MMWR Recomm Rep.

Erratum in

  • MMWR Recomm Rep. 2004 Aug 20;53(32):743

Update in

Abstract

This report updates the 2003 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2003;52[No. RR-8]:1-34). The 2004 recommendations include new or updated information regarding 1) influenza vaccine for children aged 6-23 months; 2) vaccination of health-care workers with live, attenuated influenza vaccine (LAIV); 3) personnel who may administer LAIV; 4) the 2004-05 trivalent inactivated vaccine virus strains: A/Fujian/411/2002 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Shanghai/361/2002-like antigens (for the A/Fujian/411/2002 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/Wyoming/3/2003 [H3N2] virus, and for the B/Shanghai/361/2002-like antigen, manufacturers may use the antigenically equivalent B/Jilin/20/2003 virus or B/Jiangsu/10/2003 virus); and 5) the assessment of vaccine supply and timing of influenza vaccination. A link to this report and other information regarding influenza can be accessed at http://www.cdc.gov/flu.

Similar articles

See all similar articles

Cited by 154 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback